Formulation: 200 µg of peptide in 200 µl TBS, pH 7.4, with 0.1% BSA and 0.02% sodium azide
Shelf life (days): 730
Notes: To be used in conjunction with Cayman’s PHLPP polyclonal antibody (Catalog No. 10007191) to block protein-antibody complex formation during immunochemical analysis of PHLPP · Protein kinase B/Akt is critical in regulating cell growth and death. Phosphorylation of a serine residue (Ser473) in a C-terminal hydrophobic motif of Akt is known to be linked to some of the most common human cancers. PHLPP dephosphorylates the hydrophobic motif of Akt and thus reduces Akt activity, resulting in a increase in the number of apoptotic cells.{13717} PHLPP levels are markedly reduced in several colon cancer and glioblastoma cell lines that have elevated Akt phosphorylation. Injection of a human glioblastoma cell line overexpressing PHLPP into mice reduced tumor size by nearly 70% compared with control animals. mRNA of PHLPP is ubiquitously expressed, with highest levels found in brain.{13717}
English
Deutsch
